Nonalcoholic fatty liver disease

NAFLD

non-alcoholic fatty liver disease: A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 K76.0
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 K76.0
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

1640

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

1640

diagram downward connector

Check minimum number of events None

1640

diagram downward connector

Include endpoints None

1640

diagram downward connector
NAFLD

Extra metadata

First used in FinnGen datafreeze DF2
Parent code in ICD-10 K76
Name in latin Degeneratio adiposa hepatis non alibi classificata

Summary Statistics

Key figures

All Female Male
Number of individuals 1578 876 702
Unadjusted prevalence (%) 0.51 0.50 0.52
Mean age at first event (years) 53.29 54.36 51.96

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.13 10.88 [7.66, 15.45] 1.4e-40 98
15 years 0.03 5.07 [3.50, 7.34] 9.6e-18 45
5 years 0.01 5.74 [3.45, 9.55] 1.8e-11 30
1 year 0.00 16.98 [9.42, 30.61] 4.4e-21 19

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: NAFLD – Nonalcoholic fatty liver disease
GWS hits: 2

Survival analyses between endpoints

Plot

before Nonalcoholic fatty liver disease
after Nonalcoholic fatty liver disease

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Nonalcoholic fatty liver disease